Cochrane International Mobility – Yu-Tian Xiao
Cochrane’s Mobility program connects applicants to learn about Cochrane review production and use through placements in host groups.
Cochrane’s Mobility program connects applicants to learn about Cochrane review production and use through placements in host groups.
This cohort study investigates the cardiovascular disease associations and genetic determinants of epicardial and pericardial adiposity.
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of…
This cohort study uses data from 3 populations to assess whether lipoprotein(a) levels are associated with cardiovascular risk independent of high-sensitivity C-reactive protein level.
Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia. The approval is based on the results…
ATLANTA — A home-based exercise intervention with protein supplementation improved physical performance at 12 weeks for older patients with frailty who underwent transcatheter aortic valve…
New online learning is now freely available about critical appraisal of rapid reviews as part of Cochrane’s flagship Evidence Essentials modules for the public.
ESC official website: Register for ESC Congress and take advantage of the best rates by registering early. The world’s largest conference in cardiovascular medicine, providing…
Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.
MedAxiom is the cardiovascular community’s premier source for organizational performance solutions.
Nominations are due by June 23, 2023. Submit your nominations today!